Skip to main content
Premium Trial:

Request an Annual Quote

OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer

NEW YORK – Diagnostics developer OraSure Technologies' stock on the Nasdaq rose as much as nearly 12 percent on heavy volume on Monday following a report that the firm had declined an acquisition offer from Quidel.

As reported by Street Insider, a source at OraSure claimed that Quidel made a bid to acquire the Bethlehem, Pennsylvania, immunoassay developer and microbiome testing services provider.

The story called the bid a "takeover approach" and said it was "rejected" by OraSure. The story also suggested that OraSure is evaluating starting a sales process after the bid.

On the news, OraSure's stock rose as high as $11.09 per share on Monday though the gains retreated during the day and closed up almost 3 percent at $10.20. Almost 4.8 million shares were traded during the day, compared to the average daily volume of 913,788.

On Tuesday, OraSure's shares were down a fraction of 1 percent at $10.14 in early morning trading.

Quidel's stock, meanwhile, was up 10 percent to $135.03 on the Nasdaq on Monday. In early trading Tuesday morning, its shares were down 2 percent at $132.07.

OraSure did not reply to a request for comment in time for publication. "We don't comment on M&A rumors," said Quidel's director of investor relations, Ruben Argueta, in an email.

Quidel closed the first quarter with $981.1 million in cash and cash equivalents on the books. During its fourth quarter and full-year earnings call in February, Quidel's CEO Douglas Bryant said, "We have cash and easy access to capital but are not compelled to acquire anything that isn't a great fit strategically."

OraSure received Emergency Use Authorization from the US Food and Drug Administration for a home-use rapid antigen assay to detect SARS-CoV-2 last month. In Q1, the firm reported a balance of $177.7 million in cash and cash equivalents.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.